Related references
Note: Only part of the references are listed.Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis
Ingrid Sidibe et al.
RADIOTHERAPY AND ONCOLOGY (2023)
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?
Fatima Tensaouti et al.
RADIOTHERAPY AND ONCOLOGY (2023)
Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy
Xuanhua P. Xie et al.
DEVELOPMENTAL CELL (2022)
FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma
Alexander F. Haddad et al.
BRAIN SCIENCES (2022)
Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
Friederike Hesse et al.
CANCER RESEARCH (2022)
Glioblastoma Stem-like Cell Detection Using Perfusion and Diffusion MRI
Tanguy Duval et al.
CANCERS (2022)
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Ryan C. Gimple et al.
NATURE REVIEWS CANCER (2022)
In vivo brain MR spectroscopy in gliomas: clinical and pre-clinical chances
Francesco Padelli et al.
CLINICAL AND TRANSLATIONAL IMAGING (2022)
Evidence-based recommendations on categories for extent of resection in diffuse glioma
Philipp Karschnia et al.
EUROPEAN JOURNAL OF CANCER (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice
Cristina Cudalbu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions
Kelly Mitchell et al.
NEURO-ONCOLOGY (2021)
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma
Martina Castellan et al.
NATURE CANCER (2021)
Imaging of intratumoral heterogeneity in high-grade glioma
Leland S. Hu et al.
CANCER LETTERS (2020)
Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells
Kenta Kuramoto et al.
FEBS JOURNAL (2020)
Higher Cho/NAA Ratio in Postoperative Peritumoral Edema Zone Is Associated With Earlier Recurrence of Glioblastoma
Yong Cui et al.
FRONTIERS IN NEUROLOGY (2020)
Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells
Laure Malric et al.
MOLECULAR CANCER RESEARCH (2019)
Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness
Aline Kowalski-Chauvel et al.
CANCERS (2019)
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Ryan C. Gimple et al.
GENES & DEVELOPMENT (2019)
In vitro neurosphere formation correlates with poor survival in glioma
Padmakrishnan C. Jayakrishnan et al.
IUBMB LIFE (2019)
In vivo characterization of brain metabolism by 1H MRS, 13C MRS and 18FDG PET reveals significant glucose oxidation of invasively growing glioma cells
Marta Lai et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs
Sveva Grande et al.
STEM CELLS INTERNATIONAL (2018)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response
Quintino Giorgio D'Alessandris et al.
NEURO-ONCOLOGY (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Multimodal MRI Can Identify Perfusion and Metabolic Changes in the Invasive Margin of Glioblastomas
Stephen J. Price et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Yan Michael Li et al.
JOURNAL OF NEUROSURGERY (2016)
Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients
James S. Cordova et al.
NEURO-ONCOLOGY (2016)
Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting
Oliver Eidel et al.
PLOS ONE (2016)
Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging
Tomas Kazda et al.
NEUROIMAGE-CLINICAL (2016)
EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma
Junxia Zhang et al.
CANCER LETTERS (2015)
Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71
Yoko Matsuda et al.
CANCER LETTERS (2015)
Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis
Bin Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes
Carlo Cusulin et al.
STEM CELL REPORTS (2015)
Evaluation of the Lactate-to-N-Acetyl-aspartate Ratio Defined With Magnetic Resonance Spectroscopic Imaging Before Radiation Therapy as a New Predictive Marker of the Site of Relapse in Patients With Glioblastoma Multiforme
Alexandra Deviers et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
3-Dimensional Magnetic Resonance Spectroscopic Imaging at 3 Tesla for Early Response Assessment of Glioblastoma Patients During External Beam Radiation Therapy
Manickam Muruganandham et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance
P. Dahan et al.
CELL DEATH & DISEASE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging
Yan Li et al.
NEURO-ONCOLOGY (2013)
Cellular Plasticity Confers Migratory and Invasive Advantages to a Population of Glioblastoma-Initiating Cells that Infiltrate Peritumoral Tissue
Patricia Ruiz-Ontanon et al.
STEM CELLS (2013)
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Paola Brescia et al.
STEM CELLS (2013)
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Michalina Janiszewska et al.
GENES & DEVELOPMENT (2012)
Human brain glioma stem cells are more invasive than their differentiated progeny cells in vitro
Bo Qiu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla
Vladimir Mlynarik et al.
NMR IN BIOMEDICINE (2012)
MR Spectroscopy Using Normalized and Non-normalized Metabolite Ratios for Differentiating Recurrent Brain Tumor from Radiation Injury
Augusto E. Elias et al.
ACADEMIC RADIOLOGY (2011)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Notch1 Is an Independent Prognostic Factor for Patients With Glioma
Jiang Li et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Metabolic state of glioma stem cells and nontumorigenic cells
Erina Vlashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Aurelie Tchoghandjian et al.
BRAIN PATHOLOGY (2010)
TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
Judit Anido et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
Justin D. Lathia et al.
CELL STEM CELL (2010)
NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts
Xing Fan et al.
STEM CELLS (2010)
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
Forrest W. Crawford et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
Suja Saraswathy et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma
Dan R. Laks et al.
STEM CELLS (2009)
SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Rosaria Maria Rita Gangemi et al.
STEM CELLS (2009)
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
Roberto Pallini et al.
CLINICAL CANCER RESEARCH (2008)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB
Sylvie Monferran et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: Predictive value for the site of postradiotherapy relapse in a prospective longitudinal study
Anne Laprie et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
Mingyu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
Jialiang Wang et al.
PLOS ONE (2008)
Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings
Ilwoo Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme
Elizabeth Cohen-Jonathan Moyal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging
Qing-Shi Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma
Keith L. Ligon et al.
NEURON (2007)
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity
Virginie Clement et al.
CURRENT BIOLOGY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
3D MRSI for resected high-grade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI
A Pirzkall et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
TR McKnight et al.
JOURNAL OF NEUROSURGERY (2002)
RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death
I Ader et al.
ONCOGENE (2002)
Share Paper
